Catheter ablation for atrial fibrillation-Single center experience

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10129662" target="_blank" >RIV/00179906:_____/12:10129662 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/12:10129662

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S0010865012001245" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0010865012001245</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2012.11.007" target="_blank" >10.1016/j.crvasa.2012.11.007</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Catheter ablation for atrial fibrillation-Single center experience

Popis výsledku v původním jazyce

Catheter ablation (CA) has become standard therapy for atrial fibrillation, especially for paroxysmal atrial fibrillation. Precise single center follow-up (FU) data (especially long-term FU data) are published infrequently. Methods: We studied 303 consecutive patients (172 males, 131 females, mean age 57 years) who underwent catheter ablation for atrial fibrillation (489 procedures) in years 2004-2012. Clinical examination, ECG, 24-h or 7-day Holter monitoring and quality of life (QoL) measurement (EQ-5D) was performed at 3, 6, 12, 18 and 24-month FU. Results: FU data longer than 6 month after the first procedure are available for 135 patients with paroxysmal, 84 patients with persistent and 48 patients with longstanding persistent AF. The success rateafter 6 month after the first procedure (sinus rhythm without AA drugs, no arrhythmias) was 48% for paroxysmal, 43% for persistent and 44% for longstanding persistent AF. The complication rate was 3.3% (16 patients, no deaths, no pulmona

Název v anglickém jazyce

Catheter ablation for atrial fibrillation-Single center experience

Popis výsledku anglicky

Catheter ablation (CA) has become standard therapy for atrial fibrillation, especially for paroxysmal atrial fibrillation. Precise single center follow-up (FU) data (especially long-term FU data) are published infrequently. Methods: We studied 303 consecutive patients (172 males, 131 females, mean age 57 years) who underwent catheter ablation for atrial fibrillation (489 procedures) in years 2004-2012. Clinical examination, ECG, 24-h or 7-day Holter monitoring and quality of life (QoL) measurement (EQ-5D) was performed at 3, 6, 12, 18 and 24-month FU. Results: FU data longer than 6 month after the first procedure are available for 135 patients with paroxysmal, 84 patients with persistent and 48 patients with longstanding persistent AF. The success rateafter 6 month after the first procedure (sinus rhythm without AA drugs, no arrhythmias) was 48% for paroxysmal, 43% for persistent and 44% for longstanding persistent AF. The complication rate was 3.3% (16 patients, no deaths, no pulmona

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

54

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

6

Strana od-do

"e369"-"e374"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—